Jose Dinis Bastos Lima da Silva
AuthID: R-001-HFV
1
TITLE: Pembrolizumab versus methotrexate, docetaxel, or cetuximab in recurrent or metastatic head and neck squamous cell carcinoma (KEYNOTE-040) : Subgroup analysis by pattern of disease recurrence Full Text
AUTHORS: Harrington, K. J.; Cohen, E. E. W.; Soulieres, D.; Dinis, J.; Licitra, L.; Ahn, M. j.; Soria, A.; Machiels, J. p.; Mach, N.; Mehra, R.; Burtness, B.; Swaby, R. F.; Lin, J.; Ge, J.; Lerman, N.; Le Tourneau, C.;
PUBLISHED: 2023, SOURCE: ORAL ONCOLOGY, VOLUME: 147
AUTHORS: Harrington, K. J.; Cohen, E. E. W.; Soulieres, D.; Dinis, J.; Licitra, L.; Ahn, M. j.; Soria, A.; Machiels, J. p.; Mach, N.; Mehra, R.; Burtness, B.; Swaby, R. F.; Lin, J.; Ge, J.; Lerman, N.; Le Tourneau, C.;
PUBLISHED: 2023, SOURCE: ORAL ONCOLOGY, VOLUME: 147
INDEXED IN: 
Scopus 
WOS
Scopus WOS